Article
H3G34-Mutant Gliomas—A Review of Molecular Pathogenesis and Therapeutic Options
15 Jul 2023
Abstract excerpt
The 2021 World Health Organization Classification of Tumors of the Central Nervous System reflected advances in understanding of the roles of oncohistones in gliomagenesis with the introduction of the H3.3-G34R/V mutant glioma to the already recognized H3-K27M altered glioma, which represent the diagnoses of pediatric-type diffuse hemispheric glioma and diffuse midline glioma, respectively. Despite advances in...
Topics
Join the communities discussing this publication.